• Halozyme Therapeutics average operating margin for 2023 was 38.76%, a 21.62% increase from 2022.
• Halozyme Therapeutics average operating margin for 2022 was 49.45%, a 21.07% decline from 2021.
• Halozyme Therapeutics average operating margin for 2021 was 62.65%, a 2376.28% decline from 2020.

Operating margin can be defined as operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc.